CPIX
Cumberland Pharmaceuticals Inc -Vibativ Receives Marketing Approval in China
时间：2025-02-18 20:33:49 市场： 美股 综合
Cumberland Pharmaceuticals Inc - Increases Max Aggregate Shares Offering Price to $10 Million
时间：2025-02-15 05:29:11 市场： 美股 综合
Cumberland Pharmaceuticals Inc - Ifetroban Well-Tolerated With No Serious Drug-Related Events
时间：2025-02-04 20:30:07 市场： 美股 综合
Cumberland Pharmaceuticals Announces Breakthrough Results From the Phase 2 Fight Dmd Trial in Duchenne Muscular Dystrophy Heart Disease
时间：2025-02-04 20:30:07 市场： 美股 综合
Cumberland Pharmaceuticals Q3 Adjusted EPS USD -0.02
时间：2024-11-08 05:05:20 市场： 美股 综合
Cumberland Pharmaceuticals Receives FDA Orphan Drug and Rare Pediatric Disease Designations for New Treatment of Duchenne Muscular Dystrophy
时间：2024-11-07 06:21:49 市场： 美股 综合
Rpt-Cumberland Pharmaceuticals : Does Not Believe CMS's Determination Regarding Caldolor Is Consistent With Intent of Nopain Legislation
时间：2024-11-05 06:47:48 市场： 美股 综合
Rpt-Cumberland Pharmaceuticals Inc: CMS Excludes Caldolor From Nopain Act Separate Payment List
时间：2024-11-05 06:47:47 市场： 美股 综合
Cumberland Pharmaceuticals Inc: CMS Evaluating Options for Caldolor Payment
时间：2024-11-05 06:17:18 市场： 美股 综合
Cumberland Pharmaceuticals : Does Not Believe CMS's Determination Regarding Caldolor Is Consistent With Intent of Nopain Legislation
时间：2024-11-05 06:17:18 市场： 美股 综合